Post-IPO Equity - Tempest Therapeutics
Investment Firm
Overview
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Announced Date
Apr 27, 2022
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 EcoR1 Capital |
Round Details and Background
Tempest Therapeutics raised $15000000 on 2022-04-27 in Post-IPO Equity
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 28, 2018 |  Series B - Tempest Therapeutics | 6 | - | 70.0M |
| Oct 05, 2011 | Series A - Tempest Therapeutics | - | 5.0M | |
| Apr 27, 2022 | Post-IPO Equity - Tempest Therapeutics | 2 | - | 15.0M |
Recent Activity
There is no recent news or activity for this profile.